We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $235B
1-Year Est. Return 32.99%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
+3.99%
1 Year Est. Return
+32.99%
3 Year Est. Return
+97.19%
5 Year Est. Return
+117.91%
10 Year Est. Return
+456.21%
AUM
$124B
AUM Growth
+$20B
Cap. Flow
+$16.7B
Cap. Flow %
13.46%
Top 10 Hldgs %
20.91%
Holding
8,008
New
295
Increased
4,222
Reduced
2,579
Closed
217

Sector Composition

Rank Sector Weight
1 Technology 6.83%
2 Financials 5.79%
3 Healthcare 5.06%
4 Consumer Discretionary 4.03%
5 Industrials 3.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSCI
7451
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$3K ﹤0.01%
10
HEWG
7452
DELISTED
iShares Currency Hedged MSCI Germany ETF
HEWG
$3K ﹤0.01%
+99
New +$2.69K
AINC
7453
DELISTED
Ashford Inc.
AINC
$3K ﹤0.01%
100
-87
-47% -$4.16K
AVTA
7454
CALL
DELISTED
Avantax, Inc. Common Stock
AVTA
$3K ﹤0.01%
+100
New +$3.29K
SPPI
7455
PUT
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$3K ﹤0.01%
400
-3,300
-89% -$29.5K
SIOX
7456
CALL
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$3K ﹤0.01%
468
-82
-15% -$624
NH
7457
DELISTED
NantHealth, Inc
NH
$3K ﹤0.01%
311
-36
-10% -$366
STON
7458
DELISTED
StoneMor Inc.
STON
$3K ﹤0.01%
1,500
-111,066
-99% -$329K
LFC
7459
DELISTED
China Life Insurance Company Ltd.
LFC
$3K ﹤0.01%
233
HSTO
7460
PUT
DELISTED
Histogen Inc. Common Stock
HSTO
$3K ﹤0.01%
50
-3
-6% -$521
GWGH
7461
DELISTED
GWG Holdings, Inc
GWGH
$3K ﹤0.01%
490
-2,299
-82% -$26.7K
XONE
7462
CALL
DELISTED
The ExOne Company
XONE
$3K ﹤0.01%
300
-4,600
-94% -$37.9K
CEL
7463
DELISTED
Cellcom Israel, Ltd.
CEL
$3K ﹤0.01%
910
ZN
7464
DELISTED
Zion Oil & Gas, Inc.
ZN
$3K ﹤0.01%
8,211
-6,817
-45% -$3.69K
FOMX
7465
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$3K ﹤0.01%
1,265
+442
+54% +$1.32K
ESTRW
7466
CALL
DELISTED
Estre Ambiental, Inc
ESTRW
$3K ﹤0.01%
100,000
CRR
7467
PUT
DELISTED
Carbo Ceramics Inc.
CRR
$3K ﹤0.01%
+2,000
New +$4.42K
HOS
7468
CALL
DELISTED
Hornbeck Offshore Services, Inc.
HOS
$3K ﹤0.01%
2,600
-10,100
-80% -$13.7K
SNNA
7469
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
$3K ﹤0.01%
3,692
-561
-13% -$878
APU
7470
CALL
DELISTED
AmeriGas Partners, L.P.
APU
$3K ﹤0.01%
100
-100
-50% -$3.5K
PES
7471
DELISTED
Pioneer Energy Services Corp.
PES
$3K ﹤0.01%
12,184
-34,007
-74% -$37.2K
DGL
7472
DELISTED
Invesco DB Gold Fund
DGL
$3K ﹤0.01%
60
MACK
7473
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$3K ﹤0.01%
571
EGPT
7474
DELISTED
VanEck Egypt Index ETF
EGPT
$3K ﹤0.01%
84
IID
7475
DELISTED
VOYA INTERNATIONAL HIGH DIVIDEND EQUITY INCOME FUND
IID
$3K ﹤0.01%
500

Similar funds

Citigroup's Q2 2019 Portfolio in Review

As of Q2 2019, Citigroup held 8,008 positions worth $124B, up 19% from $104B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Citigroup deployed $16.7B of net new capital in Q2 2019, opening 295 new positions and adding to 4,222 existing holdings. Its largest new stake was Invesco Russell 1000 Dynamic Multifactor ETF: 5,950,000 shares worth $177M.

By sector, the portfolio is most concentrated in Technology at 6.8% of assets, up from 5.4% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.12B trimmed.

  • Citigroup's largest Q2 2019 buy was Invesco Russell 1000 Dynamic Multifactor ETF: 5,950,000 shares worth $177M.
  • Citigroup added most to iShares Russell 1000 Value ETF in Q2 2019, an estimated $2.43B increase.
  • Citigroup's biggest Q2 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.12B.
  • Citigroup fully exited Integrated Device Technology I in Q2 2019, selling an estimated $126M.
  • Citigroup's ten largest holdings make up 21% of its $124B portfolio in Q2 2019.
  • Citigroup opened 295 new positions and closed 217 in Q2 2019.
  • Citigroup's portfolio value rose 19% quarter-over-quarter to $124B.

Based on Citigroup's 13F filing for Q2 2019, filed 12 Aug 2019.